About Us

Key Leaders

Chairman of the Board and Chief Scientist at A*STAr
Sir David Lane

“With its proprietary antibody research technologies, CPR has great potential to create a world leading technology platform that transforms the efficacy of antibody based drugs and to contribute to a community of innovation. Since its establishment, through the research performance and other external activities such as organization of antibody symposium, I realize that CPR’s presence in Singapore and expectation from others have been increasing. I am very proud to help CPR generate a pipeline of innovative products that will help patients around the world and interact very well with Singapore international research community.”

Administration Head
Yugo Fukuhara

“Based on the fundamental principle that human resources are an invaluable asset in generating a company’s growth and development, we would like to create a corporate culture that encourages a free, vigorous and open working environment in which personal growth and self-realization can be actively supported.

Along with our innovative research technologies, I firmly believe CPR’s strengths are its multi-national talents who work enthusiastically with high ethics and pride in their mission in drug discovery research to provide with significant benefits to the patients around the world.”